United voluntarily discontinues Phase 3 trial of functional dyspepsia treatment
United announced on the 23rd that it has voluntarily decided to discontinue the Phase 3 clinical trial of the functional dyspepsia treatment (UI028).
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
The company stated, "We consulted with regulatory agencies such as the Health Insurance Review and Assessment Service and the Ministry of Food and Drug Safety to review economic feasibility, but determined that achieving the drug price target set by our company is difficult," adding, "We have decided to discontinue the Phase 3 clinical trial as continuing development is not beneficial to the company."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.